text_1: V-9302 inhibits antitumor responses by decreasing cell death and oxidative stress.
text_2: Herein we report the preclinical development of V-9302, a competitive small molecule antagonist of transmembrane glutamine flux that selectively and potently targets the amino acid transporter ASCT2.